|
|
| | 5(4H)-Oxazolone, 4-[(5-methyl-2-furanyl)methylene]-2-(3-methylphenyl)- Basic information |
| | 5(4H)-Oxazolone, 4-[(5-methyl-2-furanyl)methylene]-2-(3-methylphenyl)- Chemical Properties |
| Boiling point | 391.7±52.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | pka | 0.13±0.20(Predicted) |
| | 5(4H)-Oxazolone, 4-[(5-methyl-2-furanyl)methylene]-2-(3-methylphenyl)- Usage And Synthesis |
| Uses | PKA/AKAP-IN-1 (compound 15126) is a non-peptide inhibitor of the interaction between protein kinase A (PKA) and A kinase anchoring proteins (AKAP). PKA/AKAP-IN-1 can be utilized in research related to cAMP disturbance associated diseases[1]. | | References | [1] Enno K, et al. Non-peptidic inhibitors of akap/pka interaction. WO2006122546A1. 2006-11-23 |
| | 5(4H)-Oxazolone, 4-[(5-methyl-2-furanyl)methylene]-2-(3-methylphenyl)- Preparation Products And Raw materials |
|